Trump’s proposed generic drug tariffs trigger caution, industry sees limited near-term impact
US President Donald Trump has proposed a phased tariff framework for imported generic pharmaceuticals, under which generic drugs…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ENTOD Pharmaceuticals
ENTOD Pharmaceuticals launches COLLADERM at DERMACON 2026
Transdermal collagen gel serum introduced for regenerative skincare in India
ENTOD Pharmaceuticals supports National Myopia Week 2025 with nationwide awareness campaign
The initiative aims to expand preventive education, screenings, and community engagement across 450 districts in India
ENTOD Pharmaceuticals launches OCUBIOME, India’s first ocular probiotic blend
New formulation targets eye health by restoring ocular and gut microbiota balance, supporting long-term wellness
IDMA appoints Nikkhil K Masurkar as Vice Chairperson of R&D and Innovation Committee
Masurkar has pledged to help mobilise collaborative initiatives that promote research-led development, facilitate strategic…
ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…
Entod Pharma appoints Balasubramanian K Pillai as CFO
As CFO, he will oversee financial strategy, budgeting, and risk management, helping Entod strengthen its financial position
ENTOD Pharmaceuticals appoints Dr Anish Desai as Scientific & Research adviser
ENTOD’s current research pipeline aims to address critical healthcare challenges, including myopia, digital eye strain, and…
ENTOD Pharmaceuticals appoints Prof Vivek Padgaonkar as non-executive independent director
Former OPPI Director joins ENTOD’s board, bringing expertise in pharma policy and innovation
ENTOD Pharmaceuticals introduces new eye drop preservative system
EyeBS replaces traditional detergent-based preservatives with ionic buffer blend for improved ocular safety